Allergan subsidiary Warner Chilcott and three groups of birth control purchasers convinced a federal judge in Rhode Island to approve settlements worth US$167.5 million of claims that it used illegal patent deals to delay generic versions of Loestrin 24 PE, reported Bloomberg Law.
Judge William E. Smith gave his blessing in three separate orders Tuesday, September 2, to agreements resolving proposed class action allegations on behalf of “direct purchasers” like drug distributors, “end payers” like consumers, and “third party payers” like insurers and union pension funds.
Buyers of the contraceptives sued two Allergan subsidiaries, Warner Chilcott and Watson, in federal court alleging that the companies paid generic drugmakers to delay marketing generic versions of the drug. The cases were consolidated in the US District Court for Rhode Island.
Warner Chilcott and Watson will pay a combined US$300 million to direct and indirect purchasers of the contraceptives. The settlement, which is subject to court approval, makes no admission of wrongdoing.
Featured News
CVS Health Explores Potential Breakup Amid Investor Pressure: Report
Oct 3, 2024 by
CPI
DirecTV Acquires Dish TV, Creating 20 Million-Subscriber Powerhouse
Oct 3, 2024 by
CPI
South Korea Fines Kakao Mobility $54.8 Million for Anti-Competitive Practices
Oct 3, 2024 by
CPI
Google Offers Settlement in India’s Antitrust Case Regarding Smart TVs
Oct 3, 2024 by
CPI
Attorney Challenges NCAA’s $2.78 Billion Settlement in Landmark Antitrust Cases
Oct 3, 2024 by
nhoch@pymnts.com
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh